Navigation Links
Efficiently Insert Unique Restriction Sites into Plasmid Vectors


Perform insertion mutagenesis in less than one day

Lisa Breister Jeff Braman
Stratagene

A 28-base insertion was introduced into a plasmid vector using the QuikChange site-directed mutagenesis kit.* The insertion created three unique restriction enzyme digestion sites. Plasmid DNA isolated from 9 out of 12 randomly chosen transformed clones were digested with all 3 restriction enzymes, as judged by gel electrophoresis.

With Stratagenes QuikChange kit,1 performing site-directed mutagenesis is simple, accurate, and efficient. This method permits single and multiple bases to be easily deleted and inserted into any double-stranded plasmid vector, eliminating the need for single-stranded DNA rescue and subcloning into specialized vectors. The kit relies on high-fidelity PfuTurbo DNA polymerase,** which accurately replicates plasmid DNA, thereby minimizing second-site mutations.2 These features make the QuikChange procedure the method of choice for most mutagenesis projects.

Here we describe insertion mutagenesis of a plasmid vector, which resulted in the creation of three unique restriction enzyme recognition sites.

Site-Directed Mutagenesis

To introduce restriction enzyme recognition sites into the plasmid vector, homologous oligonucleotides (49 bases long) were constructed (Figure 1). The oligonucleotides contained ten, 5 terminal bases and eleven, 3 terminal bases homologous to the 6-kb vector. The 28 interior nucleotides destined for insertion into the vector included restriction enzyme recognition sites for Bgl II, Pst I, and Xho I.

Fig.1

Modified pBK388 vector DNA (50 ng in 0.3 l; purified using the StrataPrep plasmid miniprep kit3), QuikChange 10X reaction buffer (5 l), primers (1 l of each at a concentration of 125 ng/l), and water (40.7 l) were combined and placed in Block 1 of a RoboCycler temperature cycler, at 95C for 2 minutes. The thermal cycler was turned off to allow the samples to cool slowly to room temperature. The reaction mixture was placed on ice while adding 1 l of PfuTurbo DNA polymerase (2.5 U), QuikChange dNTP mix (1 l), and a drop of mineral oil. The reaction mixture was then placed in Block 3 of the cycler at room temperature, and the unit was turned on so the block could slowly heat to 68C. The reaction mixture was incubated at this temperature for 5 minutes followed by 18 cycles of 95C for 1 minute, 55C for 1.5 minutes, and 68C for 12 minutes. At the end of temperature cycling, 10 U (1 l) of Dpn I restriction enzyme were added, and the reaction mixture was incubated at 37C for 1 hour. Following Dpn I digestion of parental DNA, 1- and 4-l volumes of the reaction mixture were used to transform XL1-Blue supercompetent cells. The transformed cells were spread onto LB/ampicillin plates, as described in the QuikChange manual. Random ampicillin-resistant colonies were inoculated into tubes containing 1.5 ml of LB media and 100 g/ml of ampicillin and incubated with shaking for 12 hours at 37C. Plasmid DNA was purified from the cultures using the StrataPrep plasmid miniprep kit.3 Plasmid preparations were digested separately with Stratagenes Bgl II, Pst I, and Xho I restriction enzymes. Plasmid DNA was digested with all 3 enzymes in 9 out of 12 randomly chosen clones. The Bgl II, Pst I, and Xho I restriction digestion patterns for seven of the clones are shown in Figure 2, indicating that the appropriate restriction sites were successfully introduced into the plasmid vector.

Fig.2

Conclusions

These results demonstrate that a 28-base insertion, encoding three unique restriction enzyme sites, was effectively introduced into a plasmid vector using the QuikChange mutagenesis kit. Mutagenesis reactions and transformation can be completed in less than one day so putative positive clones may be examined the following day. And, because high-fidelity PfuTurbo DNA polymerase is used, random mutations are minimized, rendering this the preferred method for efficient mutagenesis.

REFERENCES
  1. Papworth, C., Bauer, J.C., and Braman, J. (1996) Strategies 9: 3-4.

  2. Hogrefe, H., et al. (1997) Strategies 10: 93-96.

  3. Braman, J. and Basehore, S. (1997) Strategies 10: 84-86.

* U.S. Patent No. 5,789,166 and patents pending
** U.S. Patent Nos. 5,545,552 and 5,866,395 and patents pending


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
2. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
3. A Unique Dimension in Biological Purity
4. Unique Histochemical Substrate Permits Dual Staining In Animal Tissue
5. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
6. Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal Performance
7. Restriction Digests of DNA Isolated with the Perfectprep Gel Cleanup Kit
8. Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping
9. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
10. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
11. Generate High-Quality, Directional Plasmid cDNA Libraries
Post Your Comments:
(Date:8/28/2014)... City, CA (PRWEB) August 28, 2014 ... sanitation products for the food processing industry, is asking ... a side-by side comparison of the E2 soap they’re ... E2 Sanitizing Foam Soap . Hand hygiene is ... in the food processing environment. Six key criteria are ...
(Date:8/28/2014)... an electronic which is not only based on ... spin and the spin-related magnetism. Spin-charge converters enable ... vice versa. Recently, the research group of Professor ... Johannes Gutenberg University Mainz in collaboration with researchers ... the first time realised a new, efficient spin-charge ...
(Date:8/28/2014)... --  SunTrust Robinson Humphrey (STRH) today announced ... equity research team in biotechnology and oilfield services.  ... research demonstrates our commitment to providing our valued ... investment decision making," said Biff Woodruff , ... make significant investments in differentiated content at a ...
(Date:8/28/2014)... (PRWEB) August 27, 2014 Scientists, researchers, ... for SPIE Laser Damage 2014 symposium. Marking ... for high-power lasers will run 14-17 September. The event ... optics and photonics . , The premier conference for ... laser damage to optical materials will engage researchers and ...
Breaking Biology Technology:Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2A new, tunable device for spintronics 2A new, tunable device for spintronics 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... Guidance and Remains on Track for Four Product Launches ... 9:00 a.m. EDT EATONTOWN, N.J., April 30 Osteotech, ... the emerging field of biologic products for regenerative healing, ... 31, 2009."During the first quarter, we continued to make ...
... Accomplished regulatory executive enhances Nfocus device development team.PALO ALTO, ... Neuromedical Inc. announced today the appointment of accomplished ... the role of Vice President of Regulatory Affairs. "Bob ... experience to Nfocus , having served 18 of ...
... shows potential for pirfenidone role in treatment of patients with ... in HCV -- Strong data from 14-day triple combination study ... InterMune, Inc. (Nasdaq: ITMN ) today announced ... 2009. InterMune reported a net loss for ...
Cached Biology Technology:Osteotech Reports First Quarter 2009 Financial Results 2Osteotech Reports First Quarter 2009 Financial Results 3Osteotech Reports First Quarter 2009 Financial Results 4Osteotech Reports First Quarter 2009 Financial Results 5Osteotech Reports First Quarter 2009 Financial Results 6Osteotech Reports First Quarter 2009 Financial Results 7Osteotech Reports First Quarter 2009 Financial Results 8Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13
(Date:8/28/2014)... have identified a handful of bacterial culprits that may ... and ulcerative colitis, using patients, own intestinal immune responses ... 28 in the journal Cell . , Trillions ... plays a critical role in the development and progression ... number of bacterial species affect a person,s susceptibility to ...
(Date:8/28/2014)... your neighbors than traditional cigarettes, but still release ... study from USC. , Scientists studying secondhand smoke ... exposure to harmful particles, with close-to-zero exposure to ... harmful metals in second-hand e-cigarette smoke were found ... contains high levels of polycyclic aromatic hydrocarbons ...
(Date:8/28/2014)... MINNEAPOLIS/ST. PAUL (August 28, 2014) Researchers at the ... for facioscapulohumeral muscular dystrophy (FSHD) to be used for ... effectiveness of potential therapies for FSHD. , The research ... Cell Reports . , There is no treatment ... the most common type of muscular dystrophy. FSHD is ...
Breaking Biology News(10 mins):Yale study identifies possible bacterial drivers of IBD 2Second-hand e-cig smoke compared to regular cigarette smoke 2UMN researchers find animal model for understudied type of muscular dystrophy 2
... of viruses to effectively combat them: That is ... received its funding commitment today. VISTRIE, which stands ... joint program grant with independent management structures receiving ... Centres. Coordinated by the German Helmholtz Centre for ...
... June 30, 2011 Jerusalem, Israel The Israeli ... industrial R&D and innovation, has released new data from ... and strategic consulting firm Applied Economics Ltd., to mark ... anniversary. The study presents the proven impact of ...
... functional properties, or traits, has been pub-lished. Scientists ... the world,s 300,000 plant species. The achievement rests ... re-search institutions. The initiative, known as TRY, is ... in Jena (Germany). Jointly coordinated with the University ...
Cached Biology News:Virtual Institute investigates virus infections 2Is governmental investment in industrial R&D paying off? 2Is governmental investment in industrial R&D paying off? 3Global plant database set to promote biodiversity research and Earth-system sciences 2
Rabbit polyclonal to ZNF261 ( Abpromise for all tested applications). entrezGeneID: 9203 SwissProtID: Q14202...
sTNF-receptor I Polyclonal Antibody 100 ug affinity purified rabbit anti-human sTNF-receptor I polyclonal antibody. Performs well in WB/Elisa/Neutralization....
Smac/DIABLO (CT) - IgG for Western Blotting, Host: Rabbit Family: Smac/DIABLO...
... The new Finnpipette Focus Long ... cone for pipetting from test ... narrow and long necked vessels. ... whatever volume you select, it ...
Biology Products: